Novartis Investigative Site

Konya 42130

1 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Relapsing Multiple Sclerosis

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling